The US Food and Drug Administration (FDA) has granted another approval for Dupixent (dupilumab), for the treatment of adults ...

In keeping with US Department of Health and Human Services Secretary Robert F Kennedy Jr’s promise to carry out the ...

Earendil Labs, a US AI-driven R&D next-generation biologics therapeutics start-up, has entered into a license agreement with French pharma major Sanofi (Euronext: SAN) for two potential first-in-class ...

Dutch gene therapy company uniQure (Nasdaq: QURE) announced that the US Food and Drug Administration (FDA) has granted ...

US President Donald Trump issued an executive order on April 15 listing several potential policy changes aimed at lowering US ...

Australian clinical-stage biotech Neurizon Therapeutics (ASX: NUZ & NUZOA), which is advancing innovative treatments for ...

Switzerland-based Addex Therapeutics, a biopharma developing a portfolio of novel small molecule allosteric modulators for ...

BigHat Biosciences, a Californian biotech with a machine learning (ML)-guided antibody discovery and development platform, ...

US gene therapy company bluebird bio (Nasdaq: BLUE) announced that after three weeks of engagement, including a timeline ...

Advisory Committee on Immunization Practices (ACIP) has voted to expand its recommendation for the use of respiratory ...

India’s Venus Remedies has secured Qualified Infectious Disease Product designation from the United States Food and Drug ...

Orforglipron is the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water ...